Skip to main content

Animations

MJFF Publications

6901 - 6910 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2020
  • 2023
  • 2019
  • 2021
  • 2019
  • 2020
  • 2025
  • 2025
  • 2023
  • Summary Details
    OPEN
    Title: Activation of parkin by a molecular glue
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41467-024-51889-3
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Validation of Fox Insight Cohort via Virtual Research Visits (4749)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4749
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Whole proteome copy number dataset in primary mouse cortical neurons
    Journal Name: Data in Brief
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.dib.2023.109336
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s disease
    Journal Name: Journal of Medical Genetics
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1136/jmedgenet-2019-106283
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Pathogenic LRRK2 regulates ciliation probability upstream of tau tubulin kinase 2 via Rab10 and RILPL1 proteins
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2005894118
    Citation Count: 81
  • Summary Details
    RESTRICTED
    Title: Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.07.010
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4725
    Citation Count: 111
  • Summary Details
    OPEN
    Title: A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-025-00889-y
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Microstructural patterns in substantia nigra subregions are associated with depression and olfactory impairments in Parkinson’s disease
    Journal Name: Clinical Neurology and Neurosurgery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.clineuro.2025.108817
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00109-6
    Citation Count: 465
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.